Atrial Fibrillation Trial, Recruiting NCT06973031 Sponsor: Kardium Inc. Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06973031
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with atrial fibrillation (an irregular heartbeat) that comes and goes or is ongoing, and it causes symptoms that keep coming back
  • You have already tried at least one medication used to control heart rhythm (a type called Class I or III antiarrhythmic drug), and it either did not work well enough or you could not tolerate it

Who may not be able to join:

  • Your atrial fibrillation has been continuous for more than 12 months
  • Your irregular heartbeat is caused by something temporary or a non-heart-related condition
  • You have had a blood clot or stroke in the past six months
  • You had a heart attack or a procedure to open blocked heart arteries (such as a stent) within the last three months
  • You had any type of heart surgery within the past six months
  • You have previously had a procedure or surgery on the left side of your heart to treat irregular heartbeat
  • You currently have an implanted heart device (such as a pacemaker or defibrillator)
  • Your body mass index (a measure of body weight relative to height) is above 40
  • The pumping strength of your heart's main chamber is below a certain level (confirm with trial site)
  • The size of a specific chamber in your heart (the left atrium) is larger than a certain measurement (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +1 (604) 248 8891

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kardium Inc.
Registry
ClinicalTrials.gov
Start date
10 June 2025
Est. completion
1 June 2028

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Effectiveness endpoint; Safety endpoint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov